Colossal Biosciences, a Dallas, TX-based company focused on de-extinction technologies, raised $120 million in an expanded Series C fundraising round led by USIT US Innovative Technology / USIT Fund with participation from Bob Robert Nelsen, Peter Jackson Sir Peter Jackson, and others. This brings the Series C total to $320 million, with total fundraising since launch exceeding $555 million.
More on Inc. →


